Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells

Elizabeth Lemm(University of Southampton), Graham Packham(University of Southampton)
Clinical Cancer Research
December 12, 2019
Cited by 16


Related Papers

No related papers found

Powered by citation graph analysis